2-Benzyl-1H-benzo[d]imidazole hydrochloride, 95.0%, 1g

N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, 95+%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,5-dichlorophenyl)propanoic acid, 97.0%, 25g

2-butyl-3-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one, 95%, 100g

2-Acetyl-7-bromofluorene>98.0%(GC)1g

3-amino-N-(2-(3-isopropyl-1,2,4-oxadiazol-5-yl)ethyl)propanamide hydrochloride, 95.0%, 250mg

N-(5-amino-2-chlorophenyl)-2-furamide, 95.0%, 1g

4-(5-Methyl-1h-pyrazol-1-yl)benzoic acid, 95+%, 1g

Sodium hydroxide, min. 99%, 2.5 kg, plastic packaging.

2,4-Dibromo-5-hydroxybenzaldehyde, 97%, 5g

1,6-Diaminohexane Dihydrochloride>98.0%(T)500g

3-[4-(TRIFLUOROMETHYL)PHENYL]PYRROLIDINE OXALATE, 95.0%, 250mg

3-Amino-4-fluorobenzoic acid, 97.0%, 1g